Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    45-year follow-up of hepatitis C virus infection in healthy young adults.

    Seeff LB, Miller RN, Rabkin CS, Buskell-Bales Z, Straley-Eason KD, Smoak BL, Johnson LD, Lee SR, Kaplan EL.

    Ann Intern Med. 2000 Jan 18;132(2):105-11.PMID: 10644270 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The natural history of hepatitis C virus infection: host, viral, and environmental factors.

    Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, Nolt K, Nelson KE, Strathdee SA, Johnson L, Laeyendecker O, Boitnott J, Wilson LE, Vlahov D.

    JAMA. 2000 Jul 26;284(4):450-6.PMID: 10904508 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

    Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, et al.

    N Engl J Med. 1996 Jun 27;334(26):1691-6.PMID: 8637513 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Natural history of acute HCV infection in hemodialysis patients.

    Espinosa M, Martin-Malo A, Alvarez de Lara MA, Gonzalez R, Rodriguez M, Aljama P.

    Clin Nephrol. 2002 Aug;58(2):143-50.PMID: 12227687 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

    Liu CJ, Chen PJ, Shau WY, Kao JH, Lai MY, Chen DS.

    Liver Int. 2003 Jun;23(3):148-55.PMID: 12955877 [PubMed - indexed for MEDLINE]Related articles

    6.

    Outcome of screening for hepatitis C virus infection based on risk factors.

    Mallette C, Flynn MA, Promrat K.

    Am J Gastroenterol. 2008 Jan;103(1):131-7. Epub 2007 Sep 25.PMID: 17894850 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.

    Guiltinan AM, Kaidarova Z, Custer B, Orland J, Strollo A, Cyrus S, Busch MP, Murphy EL.

    Am J Epidemiol. 2008 Mar 15;167(6):743-50. Epub 2008 Jan 17.PMID: 18203734 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985.

    Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA.

    Gut. 2000 Dec;47(6):845-51.PMID: 11076885 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Liver disease in anti-hepatitis C virus-positive Norwegian blood donors.

    Nordøy I, Schrumpf E, Elgjo K, Flesland O, Andersen Glende J, Orjasaeter H, Siebke JC.

    Scand J Gastroenterol. 1994 Jan;29(1):77-81.PMID: 8128181 [PubMed - indexed for MEDLINE]Related articles

    10.

    Assessment of long-term outcomes of community-acquired hepatitis C infection in a cohort with sera stored from 1971 to 1975.

    Rodger AJ, Roberts S, Lanigan A, Bowden S, Brown T, Crofts N.

    Hepatology. 2000 Sep;32(3):582-7.PMID: 10960453 [PubMed - indexed for MEDLINE]Related articles

    11.

    Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus.

    Ciancio A, Manzini P, Castagno F, D'Antico S, Reynaudo P, Coucourde L, Ciccone G, Del Piano M, Ballarè M, Peyre S, Rizzi R, Barletti C, Bruno M, Caronna S, Carucci P, Venon Wde B, De Angelis C, Morgando A, Musso A, Repici A, Rizzetto M, Saracco G.

    Ann Intern Med. 2005 Jun 7;142(11):903-9.PMID: 15941697 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population.

    Kondili LA, Chionne P, Costantino A, Villano U, Lo Noce C, Pannozzo F, Mele A, Giampaoli S, Rapicetta M.

    Gut. 2002 May;50(5):693-6.PMID: 11950818 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection.

    Alberti A, Noventa F, Benvegnù L, Boccato S, Gatta A.

    Ann Intern Med. 2002 Dec 17;137(12):961-4.PMID: 12484711 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Natural history of hepatitis C.

    Seeff LB.

    Hepatology. 1997 Sep;26(3 Suppl 1):21S-28S. Review.PMID: 9305659 [PubMed - indexed for MEDLINE]Related articles

    15.

    A controlled study of hepatitis C transmission by organ transplantation. The New England Organ Bank Hepatitis C Study Group.

    Pereira BJ, Wright TL, Schmid CH, Levey AS.

    Lancet. 1995 Feb 25;345(8948):484-7. Erratum in: Lancet 1995 Mar 11;345(8950):662. Lancet 1995 Mar 4;345(8949):662. PMID: 7532254 [PubMed - indexed for MEDLINE]Related articles

    16.

    Late liver-related mortality from complications of transfusion-acquired hepatitis C.

    Kamitsukasa H, Harada H, Tanaka H, Yagura M, Tokita H, Ohbayashi A.

    Hepatology. 2005 Apr;41(4):819-25.PMID: 15793849 [PubMed - indexed for MEDLINE]Related articles

    17.

    Long-term outcome of chronic hepatitis C infection in a low-prevalence area.

    Verbaan H, Hoffmann G, Lindgren S, Nilsson S, Widell A, Eriksson S.

    Scand J Gastroenterol. 1998 Jun;33(6):650-5.PMID: 9669639 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Nine-year follow-up of hepatitis C virus infection in a rural area of Hebei province, China]

    Fan WM, Zhu WF, Zhang SY, Wang QX, Yin LM, Wan H, Gao Y, Tian XL, Yu M, Jin J, Xu XY, Wei L, Zhuang H.

    Zhonghua Yi Xue Za Zhi. 2004 Mar 2;84(5):392-6. Chinese. PMID: 15061992 [PubMed - indexed for MEDLINE]Related articles

    19.

    Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.

    Bird SM, Goldberg DJ, Hutchinson SJ.

    J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85.PMID: 11437088 [PubMed - indexed for MEDLINE]Related articles

    20.

    A cohort study of chronic liver disease in an HCV hyperendemic area of Japan: a prospective analysis for 12 years.

    Nagao Y, Tanaka K, Kobayashi K, Kumashiro R, Sata M.

    Int J Mol Med. 2004 Feb;13(2):257-65.PMID: 14719132 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data